click below
click below
Normal Size Small Size show me how
59 60 61 62 63 drugs
paramedic drugs
Question | Answer |
---|---|
Description: this is an injectable NSAID that exhibits analgesic, anti-inflammatory, and antipyretic properties without sedative effects | KETOROLAC |
Indications: mild or moderate pain | KETOROLAC |
Contraindications: hypersensitivity to ketorolac, aspirin, or other NSAIDs; asthma | KETOROLAC |
Precautions: peptic ulcers, renal or hepatic impairment, elderly | KETOROLAC |
Dosage/Route: 30 mg IV/IM (15 mg >65 years or weighs <50kg) | KETOROLAC |
Description: this is a beta blocker with some alpha blocker characteristics. it induces vasodilation, reduces peripheral vascular resistance, and lowers blood pressure | LABETALOL |
Indications: acute hypertensive crisis | LABETALOL |
Contraindications: asthma, CHF, 2nd-3rd degree heart block, severe bradycardia, cardiogenic shock | LABETALOL |
Precautions: COPD, heart failure, hepatic impairment, diabetes, peripheral vascular disease | LABETALOL |
Dosage/Route: 10 mg slow IV, then 20-40 mg/10 min as needed, up to 150 mg or a bolus of 10 mg, then continuous drip of 2-8 mg/min | LABETALOL |
Description: this is an antidysrhythmic that suppresses automaticity and raises stimulation threshold of the ventricles. it also causes sedation, anticonvulsant, and analgesic effects | LIDOCAINE |
Indications: pulseless ventricular tachycardia, ventricular fibrillation, ventricular tachycardia (w/pulse) | LIDOCAINE |
Contraindications: hypersensitivity to amide-type local anesthetics, supraventricular dysrhythmias, strokes-adams syndrome, 2nd and 3rd degree heart block, bradycardias | LIDOCAINE |
Precautions: hepatic or renal impairment, CHF, hypoxia, respiratory depression, hypovolemia, myasthenia gravis, shock, devilitated patients, elderly, family history of malignant hypothermia | LIDOCAINE |
Dosage/Route: cardiac arrest: 1-1.5 mg/kg IV/IO repeated at .5-.75 every 5-10 min up to 3 mg/kg, follow conversion with a drip of 1-4 mg/min. Ped: 1 mg/kg IV/IO, to 100mg, follow conversion with a drip of 20-50 mcg/kg/min | LIDOCAINE |
Dosage/Route: Ventricular Tachycardia (w/pulse): .5-1.5 mg/kg slow IV/IO. May repeat at one-half dose every 5-10 min until conversion up to 3 mg/kg. follow conversion with an infusion of 1-4mg/min. Ped: 1mg/kg IV/IO, followed by a drip at 20-50mcg/kg/min | LIDOCAINE |
Description: this is the most potent benzodiazepine available. it has strong antianxiety, sedative, hypnotic, and skeletal muscle relaxant properties, and a relatively short half-life | LORAZEPAM |
Indications: sedation for cardioversion and status epilepticus | LORAZEPAM |
Contraindications: sensitivity to benzodiazepines | LORAZEPAM |
Precautions: narrow-angle glaucoma, depression or psychosis, coma, shock, acute alcohol intoxication, renal or hepatic impairment, organic brain syndrome, myasthenia gravis, GI disorders, elderly, devilitated, limited pulmonary reserve | LORAZEPAM |
Dosage/Route: Sedation: 1-4 mg IM, .5-2 mg IV. Ped: .03-.5 mg/kg IV/IM/PR up to 4mg. Status Epilepticus: 2mg slow IV/PR (2mg/min). ped: .1 mg/kg slow IV/PR (2-5min) | LORAZEPAM |
Description: this is an electrolyte that acts as a calcium channel blocker, acting as a CNS depressant and anticonvulsant. it also depresses the function of smooth, skeletal, and cardiac muscles | MAGNESIUM SULFATE |
Indications: torsade de pointes, eclamptic seizures. in children for status asthmaticus nonresponsive to beta agents | MAGNESIUM SULFATE |
Contraindications: heart block, myocardial damage, shock, persistent hypertension, hypocalcemia | MAGNESIUM SULFATE |
Precautions: renal impairment, digitalized patients, other CNS depressants, neuromuscular blocking agents | MAGNESIUM SULFATE |
Dosage/Route: Cardiac Arrest: 1-2 g d diluted in 10 mL of D5W IV/IO. Ped: 25-50 mg/kg IV/IO, max dose 2g | MAGNESIUM SULFATE |
Dosage/Route: Torsades: 1-2g diluted in 50-100mL of D5W over 5-60 min. follow with .5-1g per hour IV titrated to effect Ped: 25-50 mg/kg IV/IO (max dose 2g) over 15-20 min | MAGNESIUM SULFATE |
Dosage/Route: Status Asthmaticus (pediatric only): 25-50 mg/kg IV/IO over 15-30 min. max dose 2g. Eclampsia: 2-4g IV/IM | MAGNESIUM SULFATE |